CD8+ T Cells Protect During Vein Graft Disease Development
Aims: Vein grafts are frequently used conduits for arterial reconstruction in patients with cardiovascular disease. Unfortunately, vein graft disease (VGD) causes diminished patency rates. Innate immune system components are known to contribute to VGD. However, the role of T cells has yet to be esta...
Main Authors: | Karin H. Simons, Margreet R. de Vries, Hendrika A. B. Peters, J. Wouter Jukema, Paul H. A. Quax, Ramon Arens |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcvm.2019.00077/full |
Similar Items
-
Inflammation in Vein Graft Disease
by: Margreet R. de Vries, et al.
Published: (2018-01-01) -
Phosphorylcholine Monoclonal Antibody Therapy Decreases Intraplaque Angiogenesis and Intraplaque Hemorrhage in Murine Vein Grafts
by: Fabiana Baganha, et al.
Published: (2022-11-01) -
Prolonged Hyperoxygenation Treatment Improves Vein Graft Patency and Decreases Macrophage Content in Atherosclerotic Lesions in ApoE3*Leiden Mice
by: Laura Parma, et al.
Published: (2020-02-01) -
Myeloid PHD2 Conditional Knockout Improves Intraplaque Angiogenesis and Vascular Remodeling in a Murine Model of Venous Bypass Grafting
by: Thijs J. Sluiter, et al.
Published: (2024-02-01) -
Efficacy of Intraoperative Vein Graft Storage Solutions in Preserving Endothelial Cell Integrity during Coronary Artery Bypass Surgery
by: Francesca Toto, et al.
Published: (2022-02-01)